Exponent (NASDAQ:EXPO) Posts Earnings Results

Exponent (NASDAQ:EXPO) issued its quarterly earnings data on Thursday. The business services provider reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.13, Briefing.com reports. The firm had revenue of $137.21 million for the quarter, compared to analysts’ expectations of $125.98 million. Exponent had a net margin of 18.69% and a return on equity of 28.49%. The business’s quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.56 EPS.

Exponent Stock Performance

Shares of EXPO traded up $16.81 during midday trading on Friday, hitting $96.49. 668,145 shares of the company traded hands, compared to its average volume of 308,158. The stock has a market cap of $4.89 billion, a price-to-earnings ratio of 49.94 and a beta of 0.68. The firm has a 50 day moving average of $79.55 and a 200-day moving average of $81.92. Exponent has a 52 week low of $64.61 and a 52 week high of $102.72.

Exponent Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, March 8th were paid a $0.28 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $1.12 annualized dividend and a yield of 1.16%. This is a boost from Exponent’s previous quarterly dividend of $0.26. Exponent’s payout ratio is presently 57.44%.

Insider Transactions at Exponent

In related news, insider Eric Guyer sold 3,367 shares of the stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $78.49, for a total transaction of $264,275.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.20% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on EXPO shares. Truist Financial reduced their target price on shares of Exponent from $110.00 to $95.00 and set a “buy” rating for the company in a report on Friday, February 2nd. StockNews.com raised Exponent from a “sell” rating to a “hold” rating in a research note on Monday, March 4th.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.